Dow Jones

44 303,40

-0,99%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Bausch plus Lomb Corporation (BLCO)
Bausch plus Lomb Corporation (BLCO) Actualités

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:BLCO

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
06/02/2025	13h00	Business Wire	Bausch + Lomb Provides Update on Potential Sale	NYSE:BLCO	Bausch plus Lomb Corporation
22/01/2025	13h00	Business Wire	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19	NYSE:BLCO	Bausch plus Lomb Corporation
13/01/2025	13h00	Business Wire	Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences	NYSE:BLCO	Bausch plus Lomb Corporation
13/01/2025	12h00	Business Wire	Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union	NYSE:BLCO	Bausch plus Lomb Corporation
07/01/2025	13h00	Business Wire	Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge	NYSE:BLCO	Bausch plus Lomb Corporation
02/01/2025	13h00	Business Wire	Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference	NYSE:BLCO	Bausch plus Lomb Corporation
26/12/2024	22h19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:BLCO	Bausch plus Lomb Corporation
12/12/2024	13h00	Business Wire	Bausch + Lomb Responds to Rumors of a Potential Sale	NYSE:BLCO	Bausch plus Lomb Corporation
11/12/2024	12h59	Business Wire	Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities	NYSE:BLCO	Bausch plus Lomb Corporation
14/11/2024	13h00	Business Wire	Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs	NYSE:BLCO	Bausch plus Lomb Corporation
01/11/2024	21h27	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BLCO	Bausch plus Lomb Corporation
30/10/2024	21h32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:BLCO	Bausch plus Lomb Corporation
30/10/2024	12h00	Business Wire	Bausch + Lomb Announces Third-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
14/10/2024	13h00	Business Wire	Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens	NYSE:BLCO	Bausch plus Lomb Corporation
09/10/2024	14h00	Business Wire	Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30	NYSE:BLCO	Bausch plus Lomb Corporation
01/10/2024	13h00	Business Wire	Bausch + Lomb Launches Opal™ Digital Marketplace in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
17/09/2024	12h42	IH Market News	Investors Anticipate Retail Sales Data and Fed Decision; Oil Prices Dip as Investors Weigh U.S. Production	NYSE:BLCO	Bausch plus Lomb Corporation
01/08/2024	22h48	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:BLCO	Bausch plus Lomb Corporation
31/07/2024	13h00	Business Wire	Bausch + Lomb Announces Second-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation
11/07/2024	18h05	Business Wire	Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31	NYSE:BLCO	Bausch plus Lomb Corporation
08/07/2024	13h00	Business Wire	Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief	NYSE:BLCO	Bausch plus Lomb Corporation
17/06/2024	13h00	Business Wire	Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress	NYSE:BLCO	Bausch plus Lomb Corporation
10/06/2024	13h00	Business Wire	Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
03/06/2024	13h00	Business Wire	Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States	NYSE:BLCO	Bausch plus Lomb Corporation
29/05/2024	22h30	Business Wire	Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results	NYSE:BLCO	Bausch plus Lomb Corporation
28/05/2024	15h00	Business Wire	Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®	NYSE:BLCO	Bausch plus Lomb Corporation
28/05/2024	12h59	Business Wire	Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens	NYSE:BLCO	Bausch plus Lomb Corporation
07/05/2024	15h09	IH Market News	Futures Pointing To Roughly Flat Open On Wall Street	NYSE:BLCO	Bausch plus Lomb Corporation
06/05/2024	22h34	IH Market News	U.S. Stocks See Further Upside Amid Renewed Interest Rate Optimism	NYSE:BLCO	Bausch plus Lomb Corporation
01/05/2024	12h58	Business Wire	Bausch + Lomb Announces First-Quarter 2024 Results	NYSE:BLCO	Bausch plus Lomb Corporation